Dynavax Technologies | Leverandørgjeld



Trade Creditors Endring Dato
AbbVie 2.94B 2.66B 2024-12
Adma Biologics USD 20.22M 4.2M 2024-12
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.46B 781M 2024-12
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Dynavax Technologies USD 9.06M 1.97M 2024-12
Gilead Sciences USD 833M 70M 2024-12
Glaxosmithkline 3.46B 10.01B 2024-12
Merck USD 4.08B 493M 2024-12
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
TG Therapeutics 41.97M 34.78M 2024-09
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Dynavax Technologies Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.